Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F1GKJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,549
Award facts
- Contract value 100% obligated
- $11,548.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,548.80 on January 27, 2026, for REPATHA 140 MG/ML SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 28, 2026, funded by the Defense Logistics Agency (DLA), which procures medical supplies and pharmaceuticals for the Department of Defense and military healthcare systems. The delivery order represents a task under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), and has demonstrated significant capability in fulfilling federal medical procurement requirements through competitive contracting. The company's extensive portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. REPATHA, a prescription medication used to treat high cholesterol, exemplifies the cardiovascular and specialty pharmaceutical products that AmerisourceBergen provides to support military treatment facilities and federal healthcare systems through its established contract vehicles with the DLA.
Quick answers
Who was awarded contract SPE2DR26F1GKJ?
SPE2DR26F1GKJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F1GKJ worth?
The government has obligated $11,549 on SPE2DR26F1GKJ.
Is contract SPE2DR26F1GKJ an order under another contract?
Yes. SPE2DR26F1GKJ is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GKJ competed?
The extent of competition for SPE2DR26F1GKJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award